232 related articles for article (PubMed ID: 18095008)
1. Less nausea, emesis, and constipation comparing hydromorphone and morphine? A prospective open-labeled investigation on cancer pain.
Wirz S; Wartenberg HC; Nadstawek J
Support Care Cancer; 2008 Sep; 16(9):999-1009. PubMed ID: 18095008
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
[TBL] [Abstract][Full Text] [Related]
3. Patient Controlled Subcutaneous Analgesia of Hydromorphone Versus Morphine to Treat Moderate and Severe Cancer Pain: A Randomized Double-Blind Controlled Trial.
Zeng X; Zhu J; Li J; Chen C; Sang L; Liu M; Song L; Liu H
J Pain Symptom Manage; 2024 Jan; 67(1):50-58. PubMed ID: 37742793
[TBL] [Abstract][Full Text] [Related]
4. Satisfactory Analgesia with Minimal Emesis in Day Surgeries (SAME DayS): a protocol for a randomised controlled trial of morphine versus hydromorphone.
Shanthanna H; Paul J; Lovrics P; Devereaux PJ; Bhandari M; Thabane L
BMJ Open; 2018 Jun; 8(6):e022504. PubMed ID: 29934395
[TBL] [Abstract][Full Text] [Related]
5. Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study.
Lawlor P; Turner K; Hanson J; Bruera E
Pain; 1997 Aug; 72(1-2):79-85. PubMed ID: 9272790
[TBL] [Abstract][Full Text] [Related]
6. Satisfactory analgesia with minimal emesis in day surgeries: a randomised controlled trial of morphine versus hydromorphone.
Shanthanna H; Paul J; Lovrics P; Vanniyasingam T; Devereaux PJ; Bhandari M; Thabane L
Br J Anaesth; 2019 Jun; 122(6):e107-e113. PubMed ID: 31027915
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
[TBL] [Abstract][Full Text] [Related]
8. Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone.
Collins JJ; Geake J; Grier HE; Houck CS; Thaler HT; Weinstein HJ; Twum-Danso NY; Berde CB
J Pediatr; 1996 Nov; 129(5):722-8. PubMed ID: 8917240
[TBL] [Abstract][Full Text] [Related]
9. The side effects of morphine and hydromorphone patient-controlled analgesia.
Hong D; Flood P; Diaz G
Anesth Analg; 2008 Oct; 107(4):1384-9. PubMed ID: 18806056
[TBL] [Abstract][Full Text] [Related]
10. Morphine or hydromorphone: which should be preferred? A systematic review.
Spénard S; Gélinas C; D Trottier E; Tremblay-Racine F; Kleiber N
Arch Dis Child; 2021 Oct; 106(10):1002-1009. PubMed ID: 33461958
[TBL] [Abstract][Full Text] [Related]
11. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
[TBL] [Abstract][Full Text] [Related]
12. A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction.
Ishihara M; Ikesue H; Matsunaga H; Suemaru K; Kitaichi K; Suetsugu K; Oishi R; Sendo T; Araki H; Itoh Y;
Clin J Pain; 2012 Jun; 28(5):373-81. PubMed ID: 22156893
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal adverse effects associated with the use of intravenous oliceridine compared with intravenous hydromorphone or fentanyl in acute pain management utilizing adjusted indirect treatment comparison methods.
Biskupiak J; Oderda G; Brixner D; Wandstrat TL
J Comp Eff Res; 2024 May; 13(5):e230041. PubMed ID: 38497192
[No Abstract] [Full Text] [Related]
14. Pharmaceutical interventions facilitate premedication and prevent opioid-induced constipation and emesis in cancer patients.
Ishihara M; Iihara H; Okayasu S; Yasuda K; Matsuura K; Suzui M; Itoh Y
Support Care Cancer; 2010 Dec; 18(12):1531-8. PubMed ID: 19921282
[TBL] [Abstract][Full Text] [Related]
15. Analgesia after Cesarean delivery: a retrospective comparison of intrathecal hydromorphone and morphine.
Beatty NC; Arendt KW; Niesen AD; Wittwer ED; Jacob AK
J Clin Anesth; 2013 Aug; 25(5):379-383. PubMed ID: 23965210
[TBL] [Abstract][Full Text] [Related]
16. Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial.
Narabayashi M; Saijo Y; Takenoshita S; Chida M; Shimoyama N; Miura T; Tani K; Nishimura K; Onozawa Y; Hosokawa T; Kamoto T; Tsushima T;
Jpn J Clin Oncol; 2008 Apr; 38(4):296-304. PubMed ID: 18326541
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy comparison between morphine sulfate controlled-released tablet and morphine hydrochloride sustained-released tablet in treating cancer pain].
Yao WX; Zhou H; Wang LY; Wei Y; Liu XY
Ai Zheng; 2007 Dec; 26(12):1357-9. PubMed ID: 18076801
[TBL] [Abstract][Full Text] [Related]
18. Epidural morphine vs hydromorphone in post-caesarean section patients.
Halpern SH; Arellano R; Preston R; Carstoniu J; O'Leary G; Roger S; Sandler A
Can J Anaesth; 1996 Jun; 43(6):595-8. PubMed ID: 8773867
[TBL] [Abstract][Full Text] [Related]
19. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
20. Effects of hydromorphone and morphine intravenous analgesia on plasma motilin and postoperative nausea and vomiting in patients undergoing total hysterectomy.
Liu Y; Yang L; Tao SJ
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5697-5703. PubMed ID: 30229847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]